Imagine a world where protecting yourself from HIV is as simple as visiting an online pharmacy or using your phone. For thousands in Kenya, an innovative ePrEP model is making this a reality, delivering stigma-free and accessible HIV prevention that meets people where they are. At its core, ePrEP is transforming HIV prevention by prioritizing privacy, convenience, and client-centered care.
Reading time: 3 minutes
A pill that’s saving lives
Consistent pre-exposure prophylaxis (PrEP) has proven to be a game-changer in the fight against HIV, reducing the risk of infection by up to 95%. Together with other preventive tools, PrEP has contributed to a 60% drop in global infections since the epidemic’s peak in 1995.
But there’s still work to be done. While millions stand to benefit, fewer than 8 million people worldwide are currently on PrEP. High-risk groups—like young people in Eastern and Southern Africa—continue to face obstacles, including stigma, long waiting time at clinics, and limited access to services due to long distance to facilities and high transport costs.
Breaking barriers with ePrEP and PEP
ePrEP addresses these challenges by providing prevention options through e-pharmacies and telemedicine, offering clients a private, judgment-free way to access care—particularly those facing societal stigma or logistical barriers. Developed collaboratively with MyDAWA, a Kenyan online pharmacy and telehealth provider, and Audere and the University of Washington, this innovative model ensures accessible and equitable care.
“A young girl may be more concerned about preventing pregnancy than HIV. Bundling emergency contraception with HIV preventive tools ensures we address her needs holistically,” says Dr. Daniel Were, Jhpiego’s project director of the e-PrEP Kenya Project.
By addressing stigma and tailoring services to clients’ realities, ePrEP isn’t just a new way to deliver care—it’s an enabler for individuals to take control of their health.
The role of private-sector partnerships
Platforms like MyDAWA are revolutionizing HIV prevention, making PrEP more accessible through private-sector partnerships. Online pharmacies are becoming vital touchpoints for people who avoid traditional clinics; they can complement public health systems and ensure more equitable access to prevention tools.
Accessibility is key: the convenience factor
Lessons from online PrEP delivery underscore one critical insight: convenience drives engagement. A study from the PharmPrEP project highlights that convenience is key to engagement—nearly 80% of individuals referred to public health facilities for PrEP and post-exposure prophylaxis did not follow through, whereas 90% opted for pharmacy-based services when given the choice. These findings emphasize the effectiveness of pharmacies in improving access and adherence.
“When care is stigma-free, easy, and comprehensive, people engage,” Dr. Were emphasizes.
Scaling up for impact
The potential for ePrEP to transform HIV prevention is immense. To scale this solution, Jhpiego is collaborating with governments and private-sector partners to recognize pharmacy-based and telehealth models as essential pathways to care.
“It’s about bridging gaps and creating sustainable systems,” says Dr. Were. “When public and private sectors collaborate, prevention tools can reach everyone, everywhere.”
A future with zero new HIV infections
For decades, innovation and progress have defined the global HIV response. Effective options such as ePrEP, supported by bold partnerships, offer a renewed hope for ending the epidemic. Together, with sustained action and collaboration, the vision of a world free from HIV can become a reality.
Read More About ePrEP’s Transformative Impact.
Joan Nduta is Jhpiego’s Senior Communications Manager, Africa Region.